Pfizer Expects $54 Billion in Profits in 2022 From COVID-19 Vaccines and Treatments Alone
Shane Trejo
|
Pharmaceutical giant Pfizer is expecting $54 billion in profits from COVID-19 treatments and vaccines this year as the brain-addled public lines up to be hoodwinked over and over after being subjected to mass hysteria propaganda for years.
They expect an astonishing $32 billion in revenue for their vaccinations as well as an additional $22 billion in revenue from Paxlovid, their antiviral COVID-19 treatment pill that is being pushed instead of ivermectin and hydroxychloroquine.
Pfizer’s revenue nearly doubled to $81.3 billion last year from $41.6 billion in 2020. They have a tremendous financial incentive to keep the hysteria going, even if COVID-19 no longer poses a major threat to the public. Consumer watchdogs are sounding the alarm about the corrupt motives of this monolithic drug corporation.
“The development of mRNA vaccines should have revolutionized the global COVID response. But we’ve let Pfizer withhold this essential medical innovation from much of the world, all while ripping off public health systems with an eye-watering mark-up,” said Tim Bierley of Global Justice Now, who accused Pfizer of behavior that is “nothing short of pandemic profiteering.”
“Right now, there are billions of people who cannot access COVID-19 vaccines and treatments. Many are in countries with the facilities needed to manufacture mRNA jabs, but Pfizer’s jealous guarding of its patent stands in the way. And we’re seeing thousands of preventable deaths each day as a result,” Bierley added.
Big League Politics has reported on Pfizer’s despicable business practices throughout the COVID-19 pandemic:
“The Food and Drug Administration (FDA) is now saying that it will take 75 years, rather than their initial estimate of 55 years, to produce clinical data to the public on Pfizer’s COVID-19 vaccine.
The FDA is telling a court of law that they discovered 59,000 more pages of the clinical data that it will have to produce to the public. They now claim they can analyze more than 500 pages per month, but the additional pages will add two decades to the initial estimate of time it will take to produce the documents.
“If you find what you are reading difficult to believe—that is because it is dystopian for the government to give Pfizer billions, mandate Americans to take its product, prohibit Americans from suing for harms, but yet refuse to let Americans see the data underlying its licensure,” said Aaron Siri, an attorney who is working on the case.
The Public Health and Medical Professionals for Transparency brought on the case, demanding that the FDA provide the information to the public in a timely manner. This group includes Peter Doshi, an associate professor at the University of Maryland School of Pharmacy; Dr. Carole Browner, a research professor at the University of California–Los Angeles’s David Geffen School of Medicine; and Dr. Harvey Risch, a professor of epidemiology at the Yale School of Public Health.
“The entire purpose of FOIA is government transparency. In multiple recent cases, in upholding the FOIA’s requirement to ‘make the records promptly available,’ courts have required agencies, including the FDA, to produce 10,000 or more pages per month, and those cases did not involve a request nearly this important–i.e., the data underlying licensure of a liability-free product that the federal government requires nearly all Americans to receive,” Siri said.
“As the present pandemic rages on, independent review of these documents by outside scientists is urgently needed to assist with addressing the shortcomings and issues with the response to the pandemic to date,” he added.“
Pfizer is one of the most evil businesses the world has ever known. If corporate executives in Pfizer and other corporations are not brought to justice, civilization will fall to despair and ruin.
Share: